| 2022-10 | Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy | Shim, Nayeon; Jeon, Seong Ik; Yang, Suah; Park, Jung Yeon; Jo, Mihee; Kim, Jinseong; Choi, Jiwoong; Yun, Wan Su; Kim, Jeongrae; Lee, Youngjoo; Shim, Man Kyu; Kim, Yongju; Kim, Kwangmeyung |
| 2022-03 | Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses | Kim, Jeongrae; Choi, Yongwhan; Yang, Suah; Lee, Jaewan; Choi, Jiwoong; Moon, Yujeong; Kim, Jinseong; Shim, Nayeon; Cho, Hanhee; Shim, Man Kyu; Jeon, Sangmin; Lim, Dong-Kwon; Yoon, Hong Yeol; Kim, Kwangmeyung |
| 2022-10 | Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light | Choi, Jiwoong; Lee, Il Seong; Lee, Ju Seung; Jeon, Sangmin; Yun, Wan Su; Yang, Suah; Moon, Yujeong; Kim, Jinseong; Kim, Jeongrae; Choy, Seunghwan; Jeong, Chanho; Shim, Man Kyu; Kim, Tae-Il; 김광명 |
| 2022-01 | Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy | Cho, Hanhee; Shim, Man Kyu; Yang, Suah; Song, Sukyung; Moon, Yujeong; Kim, Jinseong; Byun, Youngro; Ahn, Cheol-Hee; Kim, Kwangmeyung |
| 2022-05 | Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death | Moon, Yujeong; Shim, Man Kyu; Choi, Jiwoong; Yang, Suah; Kim, Jinseong; Yun, Wan Su; Cho, Hanhee; Park, Jung Yeon; Kim, Yongju; Seong, Joon-Kyung; Kim, Kwangmeyung |
| 2022-04 | Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery | Shim, Man Kyu; Yang, Suah; Sun, In-Cheol; Kim, Kwangmeyung |
| 2022-10 | Mesenchymal Stem Cell-Mediated Deep Tumor Delivery of Gold Nanorod for Photothermal Therapy | Yun, Wan Su; Shim, Man Kyu; Lim, Seungho; Song, Sukyung; Kim, Jinseong; Yang, Suah; Hwang, Hee Sook; Kim, Mi Ra; Yoon, Hong Yeol; Lim, Dong-Kwon; Sun, In-Cheol; Kim, Kwang meyung |
| 2022-06 | Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapy | Shim, Man Kyu; Song, Su Kyung; Jeon, Seong Ik; Hwang, Kwang Yeon; Kim, Kwangmeyung |
| 2022-04 | Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation | Cho, Hanhee; Jeon, Seong Ik; Ahn, Cheol-Hee; Shim, Man Kyu; Kim, Kwangmeyung |
| 2022-08 | Cathepsin B-responsive prodrugs for cancer-targeted therapy: Recent advances and progress for clinical translation | Jeon, Seong Ik; Yang, Suah; Shim, Man Kyu; Kim, Kwangmeyung |
